Personalis, Inc. (PSNL) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 46.38M USD | Liabilities, Current |
| Cash and equivalents | 93.97M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 15.10M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $46.38M | $93.97M | (m) | $15.10M | (m) | (m) |
| 2026-03-31 | (m) | $39.05M | $73.59M | (m) | $13.02M | (m) | (m) |
| 2025-12-31 | (m) | $39.63M | $124.25M | (m) | $16.20M | (m) | (m) |
| 2025-09-30 | (m) | $36.16M | $49.97M | (m) | $14.38M | (m) | (m) |
| 2025-06-30 | (m) | $31.72M | $53.37M | (m) | $9.95M | (m) | (m) |
| 2025-03-31 | (m) | $29.89M | $71.00M | (m) | $10.97M | (m) | (m) |
| 2024-12-31 | (m) | $31.13M | $91.42M | (m) | $8.14M | (m) | (m) |
| 2024-09-30 | (m) | $36.41M | $75.80M | (m) | $13.47M | (m) | (m) |
| 2024-06-30 | (m) | $34.13M | $47.75M | (m) | $12.92M | (m) | (m) |
| 2024-03-31 | (m) | $31.37M | $43.98M | (m) | $11.35M | (m) | (m) |
| 2023-12-31 | (m) | $47.23M | $56.98M | (m) | $17.73M | (m) | (m) |
| 2023-09-30 | (m) | $32.48M | $72.19M | (m) | $13.67M | (m) | (m) |
| 2023-06-30 | (m) | $28.59M | $97.19M | (m) | $10.13M | (m) | (m) |
| 2023-03-31 | (m) | $34.14M | $87.17M | (m) | $18.10M | (m) | (m) |
| 2022-12-31 | (m) | $33.13M | $89.13M | (m) | $16.64M | (m) | (m) |
| 2022-09-30 | (m) | $33.74M | $83.52M | (m) | $13.59M | (m) | (m) |
| 2022-06-30 | (m) | $41.51M | $86.73M | (m) | $12.88M | (m) | (m) |
| 2022-03-31 | (m) | $39.84M | $91.59M | (m) | $13.52M | (m) | (m) |
| 2021-12-31 | (m) | $31.31M | $105.58M | (m) | $18.47M | (m) | (m) |
| 2021-09-30 | (m) | $26.52M | $79.57M | (m) | $10.53M | (m) | (m) |
| 2021-06-30 | (m) | $34.09M | $70.08M | (m) | $9.28M | (m) | (m) |
| 2021-03-31 | (m) | $38.56M | $137.09M | (m) | $8.05M | (m) | (m) |
| 2020-12-31 | (m) | $40.64M | $68.53M | (m) | $6.35M | (m) | (m) |
| 2020-09-30 | (m) | $35.90M | $133.25M | (m) | $5.90M | (m) | (m) |
| 2020-06-30 | (m) | $43.04M | $25.04M | (m) | $5.38M | (m) | (m) |
| 2020-03-31 | (m) | $52.12M | $46.69M | (m) | $5.51M | (m) | (m) |
| 2019-12-31 | (m) | $49.96M | $55.05M | (m) | $3.30M | (m) | (m) |
| 2019-09-30 | (m) | $47.39M | $87.01M | (m) | $4.45M | (m) | (m) |
| 2019-06-30 | (m) | $56.34M | $163.27M | (m) | $7.46M | (m) | (m) |
| 2018-12-31 | (m) | $57.85M | $19.74M | (m) | $4.46M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $19.78M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $22.62M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |